Clinical Trial Update: Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial investigates the combination of gemcitabine, oxaliplatin, and radiation therapy for pancreatic cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Pancreatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED